press release investor science BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant Apr 10, 2025 4:14:15 PM
talent press release investor eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO Apr 2, 2025 4:10:00 PM
press release investor eXoZymes Provides Fourth Quarter and Full Year 2024 Update Apr 2, 2025 4:05:00 PM
press release IPO investor eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025 Mar 26, 2025 4:46:17 PM
press release investor eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc. Feb 21, 2025 4:05:00 PM
press release IPO investor Nasdaq Bell Ringing to Commemorate Initial Public Offering Feb 19, 2025 7:50:28 AM
press release investor Rebranding Invizyne to eXoZymes signifies a sustainable paradigm shift in chemical production leveraging AI-engineered enzymes Feb 12, 2025 12:15:00 AM
press release investor Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol Feb 10, 2025 10:37:03 AM
biofuel press release Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities Nov 19, 2024 12:00:00 AM
press release investor Invizyne Technologies Announces Closing of Initial Public Offering Nov 14, 2024 12:00:00 AM
